Related Experiment Video
Updated: Apr 28, 2026

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins
Published on: May 24, 2024
Endovascular venous thrombolysis in children younger than 24 months
Kamlesh U Kukreja1, Matthew P Lungren2, Manish N Patel2
1Department of Radiology, Baylor College of Medicine & Texas Children's Hospital, 6701 Fannin St, Suite 470, Houston, TX 77030.
Insights
Percutaneous endovascular thrombolysis is a safe and feasible treatment for deep venous thrombosis (DVT) in infants and young children. This procedure successfully restored venous patency in all evaluated pediatric patients.
Area of Science:
- Pediatric Cardiology
- Interventional Radiology
- Vascular Surgery
Background:
- Deep venous thrombosis (DVT) in children under 24 months presents unique challenges.
- Preservation of venous access is critical for medical therapy and cardiac surgery in this age group.
- Endovascular techniques offer minimally invasive options for treating pediatric DVT.
Purpose of the Study:
- To assess the technical feasibility of percutaneous endovascular thrombolysis for extremity DVT in children younger than 24 months.
- To evaluate the safety and efficacy of this treatment modality in a pediatric population.
- To determine short-term outcomes, including venous patency and complication rates.
Main Methods:
- Retrospective review of pediatric patients undergoing endovascular therapy for DVT (January 2010 - July 2013).
- Included techniques: catheter-directed therapy (CDT) with alteplase, mechanical thrombectomy, and angioplasty.
- Evaluated indications, procedural success, and complications, with follow-up for vessel patency.
Main Results:
- Eleven children (mean age 9 months) with upper or lower extremity DVT were treated.
- Central venous catheter presence was the most common risk factor; congenital heart disease was noted in upper extremity DVT cases.
- All patients achieved venous patency; a significant thrombolysis response (Grade II or III) was observed in all. One major complication (pulmonary embolism) occurred and was managed successfully. No recurrence was noted at a mean follow-up of 11.8 months.
Conclusions:
- Percutaneous endovascular thrombolysis is technically feasible for treating extremity DVT in children under 24 months.
- The procedure demonstrates a favorable safety profile in this young pediatric population.
- Successful restoration of venous patency suggests this approach is effective for pediatric DVT management.
Purpose:
To evaluate the technical feasibility and safety of percutaneous endovascular thrombolysis for extremity deep venous thrombosis (DVT) in children < 24 months old.
Materials And Methods:
A retrospective chart review of a clinical and imaging database was performed for pediatric patients who underwent endovascular therapy for DVT between January 2010 and July 2013. Indications, techniques, technical and clinical success, and complications were reviewed. Techniques for thrombolysis included catheter-directed therapy (CDT) using alteplase infusion via a multi-side hole catheter, mechanical thrombectomy, and angioplasty. Short-term outcomes were assessed using surgical and imaging follow-up examinations for patency of the targeted vessel. Patients included 11 children (mean age, 9 mo; range, 3 wk-23 mo) who consecutively underwent endovascular thrombolysis for upper extremity (n = 6) or lower extremity (n = 5) DVT. The most common indication was preservation of venous access for future cardiac surgery or medical therapy.
Results:
The most common risk factor was the presence of a central venous catheter (10 of 11 patients). All patients with upper extremity DVT had congenital heart disease. CDT and angioplasty were performed in all patients. Venous patency was established in all patients. A grade III (95%-100%) thrombolysis response was achieved in seven patients, and a grade II (50%-95%) thrombolysis response was achieved in four patients. A major complication of pulmonary embolism occurred in one patient with upper extremity thrombolysis and was managed by intravenous systemic alteplase and heparin. No recurrence of thrombosis was found on average follow-up of 11.8 months (range, 1-41 mo).
Conclusions:
Percutaneous endovascular thrombolysis for extremity DVT is safe and technically feasible in children < 24 months old.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis I: Introduction
Pulmonary Embolism III: Nursing Management

